[One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy].

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Orvosi Hetilap

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1556/650.2016.30401PMID 26947091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

  2016cited by this paper
• Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome

  2013cited by this paper
• The success of fixed combined amlodipine/atorvastatin (Amlator®) therapy in patients with hypertension and dyslipidemia

  2013cited by this paper
• The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K.

  2011cited by this paper
• Introducing Survival and Event History Analysis

  2011cited by this paper
• The Use of a Single‐Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo‐Controlled, Multicenter Study

  2009cited by this paper
• EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

  2009cited by this paper
• Synergistic Effect of Amlodipine and Atorvastatin in Reversing LDL-Induced Endothelial Dysfunction

  2008cited by this paper
• Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen

  2008cited by this paper
• A Randomized, Placebo‐Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial

  2007cited by this paper
• The Importance of Managing Hypertension and Dyslipidemia to Decrease Cardiovascular Disease

  2007cited by this paper
• Hypertension Management: Results of a New National Survey for the Hypertension Education Foundation: Harris Interactive

  2007cited by this paper
• Resistant Hypertension: Diagnosis and Management

  2006cited by this paper
• Single‐Pill Therapy in the Treatment of Concomitant Hypertension and Dyslipidemia (The Amlodipine/Atorvastatin Gemini Study)

  2005cited by this paper
• The Burden of Adult Hypertension in the United States 1999 to 2000: A Rising Tide

  2004cited by this paper
• Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias.

  2003cited by this paper
• Risk stratification in hypertension: new insights from the Framingham Study.

  2000cited by this paper
• Investigating onset, cessation, relapse, and recovery: why you should, and how you can, use discrete-time survival analysis to examine event occurrence.

  1993cited by this paper
• Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.

  1992cited by this paper

• Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.

  2017cites this paper